tiprankstipranks
Trending News
More News >
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
US Market

Allarity Therapeutics (ALLR) Ratios

Compare
277 Followers

Allarity Therapeutics Ratios

ALLR's free cash flow for Q3 2024 was $0.00. For the 2024 fiscal year, ALLR's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.14 0.44 1.02 0.31 0.71
Quick Ratio
0.14 0.44 1.08 0.31 0.71
Cash Ratio
0.01 0.18 0.94 0.05 0.32
Solvency Ratio
-0.81 -1.26 -0.86 -0.76 -1.34
Operating Cash Flow Ratio
-0.90 -1.50 -0.73 -1.31 -2.14
Short-Term Operating Cash Flow Coverage
-9.80 -6.34 -153.57 -5.14 -18.87
Net Current Asset Value
$ -12.64M$ -7.69M$ -9.79M$ -4.84M$ -7.36M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.26 0.02 0.05 0.03
Debt-to-Equity Ratio
-0.47 1.98 0.06 0.07 0.05
Debt-to-Capital Ratio
-0.90 0.66 0.05 0.06 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.36 0.05 0.03 0.00
Financial Leverage Ratio
-4.31 7.70 2.64 1.24 1.75
Debt Service Coverage Ratio
-6.32 -5.47 -43.62 -2.35 -2.86
Interest Coverage Ratio
-36.00 -154.54 -53.22 -40.65 -5.32
Debt to Market Cap
<0.01 1.33 0.02 0.07 0.02
Interest Debt Per Share
<0.01 348.97K 209.37K 518.18K 1.10M
Net Debt to EBITDA
-0.09 -0.10 0.71 -0.25 0.04
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%100.00%
EBIT Margin
0.00%0.00%0.00%0.00%-13054.17%
EBITDA Margin
0.00%0.00%0.00%0.00%-12983.33%
Operating Profit Margin
0.00%0.00%0.00%0.00%-14675.83%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-15814.17%
Net Profit Margin
0.00%0.00%0.00%0.00%-12000.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-12000.00%
Net Income Per EBT
94.32%91.35%100.50%70.13%75.88%
EBT Per EBIT
70.38%51.01%99.85%78.40%107.76%
Return on Assets (ROA)
-100.33%-110.41%-53.69%-15.19%-45.56%
Return on Equity (ROE)
432.61%-849.63%-141.87%-18.89%-79.62%
Return on Capital Employed (ROCE)
777.83%-1037.42%-91.84%-33.11%-65.50%
Return on Invested Capital (ROIC)
1682.61%-526.26%-91.68%-22.02%-48.58%
Return on Tangible Assets
-597.74%-321.48%-123.96%-174.21%-367.63%
Earnings Yield
>-0.01%-573.69%-40.39%-14.80%-42.01%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.07
Payables Turnover
<0.01 0.02 0.15 0.04 0.00
Inventory Turnover
0.00 0.00 -0.08 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.27
Asset Turnover
0.00 0.00 0.00 0.00 <0.01
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 -0.05
Cash Conversion Cycle
-83.02K -19.01K -7.03K -8.98K 5.04K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 5.04K
Days of Inventory Outstanding
0.00 0.00 -4.63K 0.00 0.00
Days of Payables Outstanding
83.02K 19.01K 2.40K 8.98K 0.00
Operating Cycle
0.00 0.00 -4.63K 0.00 5.04K
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -1.48M -1.99M -1.87M -2.60M
Free Cash Flow Per Share
>-0.01 -1.48M -1.99M -1.87M -2.60M
CapEx Per Share
0.00 1.59K 0.00 771.87 2.06K
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 -934.28 0.00 -2.42K -1.26K
Capital Expenditure Coverage Ratio
0.00 -934.28 0.00 -2.42K -1.26K
Operating Cash Flow Coverage Ratio
-9.80 -4.50 -13.86 -4.06 -10.50
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 -84.28
Free Cash Flow Yield
>-0.01%-601.45%-22.81%-21.16%-29.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-55.31K -0.17 -2.48 -6.76 -2.38
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 285.67
Price-to-Book (P/B) Ratio
-239.28K 1.48 3.51 1.28 1.90
Price-to-Free Cash Flow (P/FCF) Ratio
-51.65K -0.17 -4.38 -4.73 -3.39
Price-to-Operating Cash Flow Ratio
-51.65K -0.17 -4.38 -4.73 -3.39
Price-to-Earnings Growth (PEG) Ratio
553.11 <0.01 -0.02 >-0.01 0.00
Price-to-Fair Value
-239.28K 1.48 3.51 1.28 1.90
Enterprise Value Multiple
-54.48K -0.26 -1.83 -5.95 -2.16
EV to EBITDA
-54.48K -0.26 -1.83 -5.95 -2.16
EV to Sales
0.00 0.00 0.00 0.00 280.99
EV to Free Cash Flow
-51.65K -0.27 -3.16 -4.93 -3.33
EV to Operating Cash Flow
-51.65K -0.27 -3.16 -4.93 -3.33
Tangible Book Value Per Share
>-0.01 -675.29K -1.24M -936.54K -1.75M
Shareholders’ Equity Per Share
>-0.01 166.64K 2.48M 6.91M 4.65M
Tax and Other Ratios
Effective Tax Rate
0.06 0.09 >-0.01 0.30 0.24
Revenue Per Share
0.00 0.00 0.00 0.00 30.87K
Net Income Per Share
>-0.01 -1.42M -3.52M -1.31M -3.70M
Tax Burden
0.94 0.91 1.01 0.70 0.76
Interest Burden
1.04 1.01 1.02 1.19 1.21
Research & Development to Revenue
0.00 0.00 0.00 0.00 53.06
SG&A to Revenue
0.00 0.00 0.00 0.00 32.25
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 2.77
Income Quality
1.07 1.05 0.56 1.43 0.70
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis